Last reviewed · How we verify
NCT04472416: VIRPA
Impact of Virtual Reality Distraction on Pain and Anxiety for Bedside Abdominal VAC Dressing Change
NA trial testing VRD in addition to standardized analgesic protocol in Pain in 40 participants. Completed in 19 September 2023.
19 September 2023
Quick facts
| Lead sponsor | University of Lausanne Hospitals |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 40 |
| Start date | 21 April 2021 |
| Primary completion | 19 September 2023 |
| Estimated completion | 19 September 2023 |
| Sites | 1 location across Switzerland |
Drugs / interventions tested
- VRD in addition to standardized analgesic protocol
Conditions studied
- Pain — all drugs for Pain →
- Anxiety — all drugs for Anxiety →
- Satisfaction, Patient — all drugs for Satisfaction, Patient →
Sponsor
University of Lausanne Hospitals
Who can join
18 and older, any sex, with Pain or Anxiety. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
We aim to study the use of a virtual reality device (VRD) in addition to our standardized analgesic care protocol for abdominal bedside VAC dressing change and we hypothesize to decrease pain and anxiety and to increase patients' comfort by this intervention.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Impact of Virtual Reality Headset on Pain and Anxiety for Bedside Abdominal VAC Dressing Change (VIRPA): A Randomized Controlled Clinical Trial.
Barberá-Carbonell B, Kefleyesus A, Djafarrian R, Geinoz S, et al · · 2026 · PMID 41737441 · DOI 10.1002/hsr2.71877
Verify or expand the search:
- PubMed search for NCT04472416
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Pain
Currently open trials in the same condition.
- NCT07533409 — Tactile and Pain Sensory Thresholds and Hand Grip Strength · recruiting
- NCT07294092 — Ketamine and Propofol NeuroImaging · EARLY_PHASE1 · recruiting
- NCT07290205 — Remimazolam NeuroImaging · EARLY_PHASE1 · recruiting
- NCT07487610 — Relationship Between Neuropathic Pain and Geriatric Assessment Parameters in Patients Aged 80 Years and Older · recruiting
- NCT07454993 — The Effect of Music During Colonoscopy · NA · recruiting
Other University of Lausanne Hospitals trials
Trials by the same sponsor.
- NCT06912906 — Feasibility Study to Compare Two Ventilatory Modes for Mechanical Ventilation Weaning · NA · not yet recruiting
- NCT06482489 — Accurate Prostate Cancer Following Using Low-Field MRI (Low-PRISM) · recruiting
- NCT06552832 — CAVEAT: An Open-Trial Feasibility Study · NA · recruiting
- NCT05927324 — Clinician-Assisted Videofeedback Exposure-Approach Therapy (CAVEAT) Trial · NA · recruiting
- NCT06320457 — A Brief Case Management Intervention for People Involuntarily Admitted to a Psychiatric Hospital · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04472416 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 9 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University of Lausanne Hospitals
- Last refreshed: 29 November 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04472416.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing